OVID Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ovid Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.37 USD 3.49% Market Closed

Market Cap: $442.3m

	Ovid Therapeutics Inc NASDAQ:OVID	US
	Premium Brands Holdings Corp F:5P7	CA
	Patriot Battery Metals Inc TSX:PMET	CA
R	Realtech AG DUS:RTC	DE
I	Instalco AB F:4II	SE
	Evaxion Biotech A/S NASDAQ:EVAX	DK
	BioLine RX Ltd NASDAQ:BLRX	IL
S	Shanghai Electric Group Co Ltd SWB:USR	CN
B	Boombit SA WSE:BBT	PL

Profitability Summary

Ovid Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-670%

Negative 3Y Average Operating Margin

-8 412%

Operating Margin is Increasing

-27 050% > -670%

Negative Net Margin

-339%

Negative 3Y Average Net Margin

-5 576%

Net Margin is Increasing

-24 650% > -339%

Negative Free Cash Flow Margin

-589%

Negative 3Y Average Free Cash Flow Margin

-6 944%

Free Cash Flow Margin is Increasing

-22 900% > -589%

Negative ROE

-19%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-152%

ROIC is Increasing

-193% > -97%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.